O	O	0	5	Alpha	Alpha	B-NP	NN	B-protein	3	NMOD	B-protein
O	O	5	6	-	-	I-NP	HYPH	O	3	NMOD	O
O	O	6	16	tocopherol	tocopherol	I-NP	NN	O	4	SUB	O
O	O	17	25	inhibits	inhibit	B-VP	VBZ	O	0	ROOT	O
O	O	26	33	agonist	agonist	B-NP	NN	O	10	NMOD	O
O	O	33	34	-	-	O	HYPH	O	10	NMOD	O
O	O	34	41	induced	induce	B-NP	VBN	O	10	NMOD	O
O	O	42	51	monocytic	monocytic	I-NP	JJ	O	10	NMOD	O
O	O	52	56	cell	cell	I-NP	NN	O	10	NMOD	O
O	O	57	65	adhesion	adhesion	I-NP	NN	O	4	OBJ	O
O	O	66	68	to	to	B-PP	TO	O	10	NMOD	O
O	O	69	77	cultured	culture	B-NP	VBN	B-cell_line	15	NMOD	B-cell_line
O	O	78	83	human	human	I-NP	JJ	I-cell_line	15	NMOD	I-cell_line
O	O	84	95	endothelial	endothelial	I-NP	JJ	I-cell_line	15	NMOD	I-cell_line
O	O	96	101	cells	cell	I-NP	NNS	I-cell_line	11	PMOD	I-cell_line
O	O	101	102	.	.	O	.	O	4	P	O

O	O	104	116	Antioxidants	Antioxidant	B-NP	NNS	O	2	SUB	O
O	O	117	121	have	have	B-VP	VBP	O	20	VMOD	O
O	O	122	126	been	be	I-VP	VBN	O	2	VC	O
O	O	127	135	proposed	propose	I-VP	VBN	O	3	VC	O
O	O	136	138	to	to	I-VP	TO	O	6	VMOD	O
O	O	139	141	be	be	I-VP	VB	O	4	VMOD	O
O	O	142	146	anti	anti	O	AFX	O	10	NMOD	O
O	O	146	147	-	-	O	HYPH	O	10	NMOD	O
O	O	147	162	atherosclerotic	atherosclerotic	B-NP	JJ	O	10	NMOD	O
O	O	163	169	agents	agent	I-NP	NNS	O	6	PRD	O
O	O	169	170	;	;	O	:	O	20	P	O
O	O	171	178	however	however	B-ADVP	RB	O	20	VMOD	O
O	O	178	179	,	,	O	,	O	20	P	O
O	O	180	183	the	the	B-NP	DT	O	15	NMOD	O
O	O	184	194	mechanisms	mechanism	I-NP	NNS	O	20	SUB	O
O	O	195	205	underlying	underlie	B-VP	VBG	O	15	NMOD	O
O	O	206	211	their	their	B-NP	PRP$	O	19	NMOD	O
O	O	212	222	beneficial	beneficial	I-NP	JJ	O	19	NMOD	O
O	O	223	230	effects	effect	I-NP	NNS	O	16	OBJ	O
O	O	231	234	are	be	B-VP	VBP	O	0	ROOT	O
O	O	235	241	poorly	poorly	I-VP	RB	O	20	VMOD	O
O	O	242	252	understood	understand	I-VP	VBN	O	20	VC	O
O	O	252	253	.	.	O	.	O	20	P	O

O	O	254	256	We	We	B-NP	PRP	O	2	SUB	O
O	O	257	261	have	have	B-VP	VBP	O	0	ROOT	O
O	O	262	270	examined	examine	I-VP	VBN	O	2	VC	O
O	O	271	274	the	the	B-NP	DT	O	5	NMOD	O
O	O	275	281	effect	effect	I-NP	NN	O	3	OBJ	O
O	O	282	284	of	of	B-PP	IN	O	5	NMOD	O
O	O	285	290	alpha	alpha	O	SYM	O	6	PMOD	O
O	O	290	291	-	-	O	HYPH	O	7	PMOD	O
O	O	291	301	tocopherol	tocopherol	B-NP	NN	O	8	OBJ	O
O	O	302	303	(	(	O	(	O	14	DEP	O
O	O	303	308	alpha	alpha	O	SYM	O	13	NMOD	O
O	O	308	309	-	-	O	HYPH	O	13	P	O
O	O	309	312	tcp	tcp	B-NP	NN	O	14	DEP	O
O	O	312	313	)	)	O	)	O	9	NMOD	O
O	O	314	316	on	on	B-PP	IN	O	9	NMOD	O
O	O	317	320	one	one	B-NP	CD	O	18	NMOD	O
O	O	321	329	cellular	cellular	I-NP	JJ	O	18	NMOD	O
O	O	330	335	event	event	I-NP	NN	O	15	PMOD	O
O	O	336	338	in	in	B-PP	IN	O	18	NMOD	O
O	O	339	354	atherosclerotic	atherosclerotic	B-NP	JJ	O	22	NMOD	O
O	O	355	361	plaque	plaque	I-NP	NN	O	22	NMOD	O
O	O	362	373	development	development	I-NP	NN	O	25	NMOD	O
O	O	373	374	,	,	O	,	O	25	P	O
O	O	375	383	monocyte	monocyte	B-NP	NN	O	25	NMOD	O
O	O	384	392	adhesion	adhesion	I-NP	NN	O	19	PMOD	O
O	O	393	395	to	to	B-PP	TO	O	25	NMOD	O
O	O	396	406	stimulated	stimulate	B-NP	VBN	O	29	NMOD	O
O	O	407	418	endothelial	endothelial	I-NP	JJ	B-cell_type	29	NMOD	B-cell_type
O	O	419	424	cells	cell	I-NP	NNS	I-cell_type	26	PMOD	I-cell_type
O	O	425	426	(	(	O	(	O	32	DEP	O
O	O	426	429	ECs	EC	B-NP	NNS	B-cell_type	32	DEP	B-cell_type
O	O	429	430	)	)	O	)	O	29	NMOD	O
O	O	430	431	.	.	O	.	O	2	P	O

O	O	432	437	Human	Human	B-NP	JJ	B-cell_type	4	NMOD	B-cell_type
O	O	438	447	umbilical	umbilical	I-NP	JJ	I-cell_type	4	NMOD	I-cell_type
O	O	448	452	vein	vein	I-NP	NN	I-cell_type	4	NMOD	I-cell_type
O	O	453	456	ECs	EC	I-NP	NNS	I-cell_type	5	SUB	I-cell_type
O	O	457	461	were	be	B-VP	VBD	O	0	ROOT	O
O	O	462	472	pretreated	pretreate	I-VP	VBN	O	5	VC	O
O	O	473	477	with	with	B-PP	IN	O	6	VMOD	O
O	O	478	483	alpha	alpha	B-NP	SYM	O	10	NMOD	O
O	O	483	484	-	-	O	HYPH	O	10	P	O
O	O	484	487	tcp	tcp	B-NP	NN	O	7	PMOD	O
O	O	488	494	before	before	B-PP	IN	O	6	VMOD	O
O	O	495	506	stimulation	stimulation	B-NP	NN	O	11	PMOD	O
O	O	507	511	with	with	B-PP	IN	O	12	NMOD	O
O	O	512	517	known	known	B-NP	JJ	O	15	NMOD	O
O	O	518	526	agonists	agonist	I-NP	NNS	O	13	PMOD	O
O	O	527	529	of	of	B-PP	IN	O	15	NMOD	O
O	O	530	538	monocyte	monocyte	B-NP	NN	O	18	NMOD	O
O	O	539	547	adhesion	adhesion	I-NP	NN	O	16	PMOD	O
O	O	547	548	:	:	O	:	O	5	P	O
O	O	549	551	IL	IL	B-NP	NN	B-protein	21	NMOD	B-protein
O	O	551	552	-	-	B-NP	HYPH	I-protein	5	P	I-protein
O	O	552	553	1	1	I-NP	CD	I-protein	47	NMOD	I-protein
O	O	554	555	(	(	I-NP	NN	O	47	NMOD	O
O	O	555	557	10	10	B-NP	CD	O	27	NMOD	O
O	O	558	560	ng	ng	I-NP	NN	O	27	NMOD	O
O	O	560	561	/	/	B-NP	SYM	O	27	P	O
O	O	561	563	ml	ml	I-NP	NN	O	47	NMOD	O
O	O	563	564	)	)	O	)	O	27	NMOD	O
O	O	564	565	,	,	O	,	O	47	P	O
O	O	566	569	LPS	LPS	B-NP	NN	O	47	NMOD	O
O	O	570	571	(	(	O	(	O	36	DEP	O
O	O	571	573	10	10	B-NP	CD	O	35	NMOD	O
O	O	574	576	ng	ng	I-NP	NN	O	35	NMOD	O
O	O	576	577	/	/	B-NP	SYM	O	35	P	O
O	O	577	579	ml	ml	I-NP	NN	O	36	DEP	O
O	O	579	580	)	)	O	)	O	30	NMOD	O
O	O	580	581	,	,	O	,	O	47	P	O
O	O	582	590	thrombin	thrombin	B-NP	NN	B-protein	47	NMOD	B-protein
O	O	591	592	(	(	O	(	O	44	DEP	O
O	O	592	594	30	30	B-NP	CD	O	43	NMOD	O
O	O	595	596	U	U	I-NP	NN	O	43	NMOD	O
O	O	596	597	/	/	B-NP	SYM	O	43	NMOD	O
O	O	597	599	ml	ml	I-NP	NN	O	44	DEP	O
O	O	599	600	)	)	O	)	O	38	NMOD	O
O	O	600	601	,	,	O	,	O	47	P	O
O	O	602	604	or	or	O	CC	O	47	NMOD	O
O	O	605	608	PMA	PMA	B-NP	NN	O	5	VMOD	O
O	O	609	610	(	(	O	(	O	51	DEP	O
O	O	610	612	10	10	B-NP	CD	O	50	NMOD	O
O	O	613	615	nM	nM	I-NP	NN	O	51	DEP	O
O	O	615	616	)	)	O	)	O	47	NMOD	O
O	O	616	617	.	.	O	.	O	5	P	O

O	O	618	625	Agonist	Agonist	B-NP	NN	O	3	AMOD	O
O	O	625	626	-	-	O	HYPH	O	1	P	O
O	O	626	633	induced	induce	B-NP	VBN	O	6	NMOD	O
O	O	634	643	monocytic	monocytic	I-NP	JJ	O	6	NMOD	O
O	O	644	648	cell	cell	I-NP	NN	O	6	NMOD	O
O	O	649	657	adhesion	adhesion	I-NP	NN	O	11	NMOD	O
O	O	657	658	,	,	O	,	O	11	P	O
O	O	659	662	but	but	O	CC	O	11	NMOD	O
O	O	663	666	not	not	O	RB	O	8	DEP	O
O	O	667	672	basal	basal	B-NP	JJ	O	11	NMOD	O
O	O	673	681	adhesion	adhesion	I-NP	NN	O	13	SUB	O
O	O	681	682	,	,	O	,	O	11	P	O
O	O	683	686	was	be	B-VP	VBD	O	0	ROOT	O
O	O	687	696	inhibited	inhibit	I-VP	VBN	O	13	VC	O
O	O	697	699	in	in	B-PP	IN	O	14	VMOD	O
O	O	700	701	a	a	B-NP	DT	O	23	NMOD	O
O	O	702	706	time	time	I-NP	NN	O	23	NMOD	O
O	O	706	707	-	-	B-NP	HYPH	O	23	NMOD	O
O	O	708	711	and	and	I-NP	CC	O	23	NMOD	O
O	O	712	725	concentration	concentration	I-NP	NN	O	23	NMOD	O
O	O	725	726	-	-	I-NP	HYPH	O	23	NMOD	O
O	O	726	735	dependent	dependent	I-NP	JJ	O	23	NMOD	O
O	O	736	742	manner	manner	I-NP	NN	O	15	PMOD	O
O	O	743	745	by	by	B-PP	IN	O	14	VMOD	O
O	O	746	751	alpha	alpha	B-NP	SYM	O	27	NMOD	O
O	O	751	752	-	-	B-VP	HYPH	O	27	NMOD	O
O	O	752	755	tcp	tcp	B-NP	NN	O	24	PMOD	O
O	O	755	756	.	.	O	.	O	13	P	O

O	O	757	760	The	The	B-NP	DT	O	2	NMOD	O
O	O	761	765	IC50	IC50	I-NP	NN	O	15	SUB	O
O	O	766	768	of	of	B-PP	IN	O	2	NMOD	O
O	O	769	774	alpha	alpha	B-NP	SYM	O	6	NMOD	O
O	O	774	775	-	-	O	HYPH	O	6	NMOD	O
O	O	775	778	tcp	tcp	B-NP	NN	O	3	PMOD	O
O	O	779	781	on	on	B-PP	IN	O	2	NMOD	O
O	O	782	784	an	an	B-NP	DT	O	14	NMOD	O
O	O	785	787	IL	IL	I-NP	NN	B-protein	10	NMOD	B-protein
O	O	787	788	-	-	B-NP	HYPH	I-protein	14	NMOD	I-protein
O	O	788	789	1	1	I-NP	CD	I-protein	10	NMOD	I-protein
O	O	789	790	-	-	B-NP	HYPH	O	10	P	O
O	O	790	797	induced	induce	I-NP	VBN	O	14	NMOD	O
O	O	798	806	response	response	I-NP	NN	O	7	PMOD	O
O	O	807	810	was	be	B-VP	VBD	O	0	ROOT	O
O	O	811	813	45	45	B-NP	CD	O	17	NMOD	O
O	O	814	820	microM	microM	I-NP	NN	O	15	PRD	O
O	O	820	821	.	.	O	.	O	15	P	O

O	O	822	825	The	The	B-NP	DT	O	2	NMOD	O
O	O	826	836	inhibition	inhibition	I-NP	NN	O	3	SUB	O
O	O	837	847	correlated	correlate	B-VP	VBD	O	0	ROOT	O
O	O	848	852	with	with	B-PP	IN	O	3	VMOD	O
O	O	853	854	a	a	B-NP	DT	O	6	NMOD	O
O	O	855	863	decrease	decrease	I-NP	NN	O	4	PMOD	O
O	O	864	866	in	in	B-PP	IN	O	6	NMOD	O
O	O	867	873	steady	steady	B-NP	JJ	O	10	NMOD	O
O	O	874	879	state	state	I-NP	NN	O	10	NMOD	O
O	O	880	886	levels	level	I-NP	NNS	O	7	PMOD	O
O	O	887	889	of	of	B-PP	IN	O	10	NMOD	O
T1	B-Protein	890	891	E	E	B-NP	NN	B-RNA	15	NMOD	B-RNA
T1	I-Protein	891	892	-	-	B-NP	HYPH	I-RNA	15	NMOD	I-RNA
T1	I-Protein	892	900	selectin	selectin	I-NP	NN	I-RNA	15	NMOD	I-RNA
O	O	901	905	mRNA	mRNA	I-NP	NN	I-RNA	19	NMOD	I-RNA
O	O	906	909	and	and	O	CC	O	19	NMOD	O
O	O	910	914	cell	cell	B-NP	NN	O	19	NMOD	O
O	O	915	922	surface	surface	I-NP	NN	O	19	NMOD	O
O	O	923	933	expression	expression	I-NP	NN	O	11	PMOD	O
O	O	934	936	of	of	B-PP	IN	O	19	NMOD	O
T2	B-Protein	937	938	E	E	B-NP	NN	B-protein	23	NMOD	B-protein
T2	I-Protein	938	939	-	-	B-NP	HYPH	I-protein	23	NMOD	I-protein
T2	I-Protein	939	947	selectin	selectin	I-NP	NN	I-protein	20	PMOD	I-protein
O	O	948	953	which	which	B-NP	WDT	O	23	NMOD	O
O	O	954	956	is	be	B-VP	VBZ	O	24	SBAR	O
O	O	957	967	consistent	consistent	B-ADJP	JJ	O	25	PRD	O
O	O	968	972	with	with	B-PP	IN	O	26	AMOD	O
O	O	973	976	the	the	B-NP	DT	O	29	NMOD	O
O	O	977	984	ability	ability	I-NP	NN	O	27	PMOD	O
O	O	985	987	of	of	B-PP	IN	O	29	NMOD	O
O	O	988	989	a	a	B-NP	DT	O	33	NMOD	O
O	O	990	1000	monoclonal	monoclonal	I-NP	JJ	B-protein	33	NMOD	B-protein
O	O	1001	1009	antibody	antibody	I-NP	NN	I-protein	30	PMOD	I-protein
O	O	1010	1012	to	to	B-PP	TO	O	29	NMOD	O
T3	B-Protein	1013	1014	E	E	B-NP	NN	B-protein	37	NMOD	B-protein
T3	I-Protein	1014	1015	-	-	B-NP	HYPH	I-protein	37	NMOD	I-protein
T3	I-Protein	1015	1023	selectin	selectin	I-NP	NN	I-protein	34	PMOD	I-protein
O	O	1024	1026	to	to	B-VP	TO	O	39	VMOD	O
O	O	1027	1034	inhibit	inhibit	I-VP	VB	O	29	NMOD	O
O	O	1035	1044	monocytic	monocytic	B-NP	JJ	O	42	NMOD	O
O	O	1045	1049	cell	cell	I-NP	NN	O	42	NMOD	O
O	O	1050	1058	adhesion	adhesion	I-NP	NN	O	39	OBJ	O
O	O	1059	1061	in	in	B-PP	IN	O	39	VMOD	O
O	O	1062	1066	this	this	B-NP	DT	O	45	NMOD	O
O	O	1067	1073	system	system	I-NP	NN	O	43	PMOD	O
O	O	1073	1074	.	.	O	.	O	3	P	O

O	O	1075	1083	Probucol	Probucol	B-NP	NN	O	15	SUB	O
O	O	1084	1085	(	(	O	(	O	5	DEP	O
O	O	1085	1087	50	50	B-NP	CD	O	4	NMOD	O
O	O	1088	1094	microM	microM	I-NP	NN	O	5	DEP	O
O	O	1094	1095	)	)	O	)	O	1	NMOD	O
O	O	1096	1099	and	and	O	CC	O	15	VMOD	O
T5	B-Entity	1100	1101	N	N	B-NP	NN	O	15	SUB	O
T5	I-Entity	1101	1102	-	-	O	HYPH	O	7	NMOD	O
T5	I-Entity	1102	1116	acetylcysteine	acetylcysteine	B-NP	NN	O	8	PMOD	O
O	O	1117	1118	(	(	O	(	O	13	DEP	O
O	O	1118	1120	20	20	B-NP	CD	O	12	NMOD	O
O	O	1121	1123	mM	mM	I-NP	NN	O	13	DEP	O
O	O	1123	1124	)	)	O	)	O	9	NMOD	O
O	O	1125	1129	also	also	B-ADVP	RB	O	15	VMOD	O
O	O	1130	1139	inhibited	inhibit	B-VP	VBD	O	0	ROOT	O
O	O	1140	1147	agonist	agonist	B-NP	NN	O	18	AMOD	O
O	O	1147	1148	-	-	O	HYPH	O	16	P	O
O	O	1148	1155	induced	induce	B-NP	VBN	O	21	NMOD	O
O	O	1156	1165	monocytic	monocytic	I-NP	JJ	O	21	NMOD	O
O	O	1166	1170	cell	cell	I-NP	NN	O	21	NMOD	O
O	O	1171	1179	adhesion	adhesion	I-NP	NN	O	15	OBJ	O
O	O	1179	1180	;	;	O	:	O	15	P	O
O	O	1181	1188	whereas	whereas	B-ADVP	IN	O	15	VMOD	O
O	O	1188	1189	,	,	O	,	O	28	P	O
O	O	1190	1197	several	several	B-NP	JJ	O	27	NMOD	O
O	O	1198	1203	other	other	I-NP	JJ	O	27	NMOD	O
O	O	1204	1216	antioxidants	antioxidant	I-NP	NNS	O	28	SUB	O
O	O	1217	1220	had	have	B-VP	VBD	O	23	SBAR	O
O	O	1221	1223	no	no	B-NP	DT	O	31	NMOD	O
O	O	1224	1235	significant	significant	I-NP	JJ	O	31	NMOD	O
O	O	1236	1242	effect	effect	I-NP	NN	O	28	OBJ	O
O	O	1242	1243	.	.	O	.	O	15	P	O

O	O	1244	1251	Protein	Protein	B-NP	NN	B-protein	3	NMOD	B-protein
O	O	1252	1258	kinase	kinase	I-NP	NN	I-protein	3	NMOD	I-protein
O	O	1259	1260	C	C	I-NP	NN	I-protein	7	SUB	I-protein
O	O	1261	1262	(	(	O	(	O	6	DEP	O
O	O	1262	1265	PKC	PKC	B-NP	NN	B-protein	6	DEP	B-protein
O	O	1265	1266	)	)	O	)	O	3	NMOD	O
O	O	1267	1271	does	do	B-VP	VBZ	O	0	ROOT	O
O	O	1272	1275	not	not	I-VP	RB	O	7	VMOD	O
O	O	1276	1282	appear	appear	I-VP	VB	O	7	VC	O
O	O	1283	1285	to	to	I-VP	TO	O	11	VMOD	O
O	O	1286	1290	play	play	I-VP	VB	O	9	VMOD	O
O	O	1291	1292	a	a	B-NP	DT	O	13	NMOD	O
O	O	1293	1297	role	role	I-NP	NN	O	11	OBJ	O
O	O	1298	1300	in	in	B-PP	IN	O	11	VMOD	O
O	O	1301	1304	the	the	B-NP	DT	O	19	NMOD	O
O	O	1305	1310	alpha	alpha	I-NP	SYM	O	19	NMOD	O
O	O	1310	1311	-	-	I-NP	HYPH	O	19	NMOD	O
O	O	1311	1314	tcp	tcp	I-NP	NN	O	19	NMOD	O
O	O	1315	1321	effect	effect	I-NP	NN	O	14	PMOD	O
O	O	1322	1327	since	since	B-PP	IN	O	7	VMOD	O
O	O	1328	1330	no	no	B-NP	DT	O	22	NMOD	O
O	O	1331	1342	suppression	suppression	I-NP	NN	O	28	SUB	O
O	O	1343	1345	of	of	B-PP	IN	O	22	NMOD	O
O	O	1346	1361	phosphorylation	phosphorylation	B-NP	NN	O	23	PMOD	O
O	O	1362	1364	of	of	B-PP	IN	O	24	NMOD	O
O	O	1365	1368	PKC	PKC	B-NP	NN	B-protein	27	NMOD	B-protein
O	O	1369	1379	substrates	substrate	I-NP	NNS	I-protein	25	PMOD	I-protein
O	O	1380	1383	was	be	B-VP	VBD	O	20	SBAR	O
O	O	1384	1392	observed	observe	I-VP	VBN	O	28	VC	O
O	O	1392	1393	.	.	O	.	O	7	P	O

O	O	1394	1404	Activation	Activation	B-NP	NN	O	10	SUB	O
O	O	1405	1407	of	of	B-PP	IN	O	1	NMOD	O
O	O	1408	1411	the	the	B-NP	DT	O	5	NMOD	O
O	O	1412	1425	transcription	transcription	I-NP	NN	B-protein	5	NMOD	B-protein
O	O	1426	1432	factor	factor	I-NP	NN	I-protein	9	NMOD	I-protein
T6	B-Entity	1433	1435	NF	NF	I-NP	NN	B-protein	9	NMOD	B-protein
T6	I-Entity	1435	1436	-	-	B-NP	HYPH	I-protein	9	NMOD	I-protein
T6	I-Entity	1436	1441	kappa	kappa	I-NP	NN	I-protein	9	NMOD	I-protein
T6	I-Entity	1442	1443	B	B	I-NP	NN	I-protein	2	PMOD	I-protein
O	O	1444	1446	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	1447	1455	reported	report	I-VP	VBN	O	10	VC	O
O	O	1456	1458	to	to	I-VP	TO	O	13	VMOD	O
O	O	1459	1461	be	be	I-VP	VB	O	11	VMOD	O
O	O	1462	1471	necessary	necessary	B-ADJP	JJ	O	17	AMOD	O
O	O	1472	1475	but	but	O	CC	O	17	AMOD	O
O	O	1476	1479	not	not	B-ADJP	RB	O	17	AMOD	O
O	O	1480	1490	sufficient	sufficient	I-ADJP	JJ	O	13	PRD	O
O	O	1491	1494	for	for	B-PP	IN	O	17	AMOD	O
T4	B-Protein	1495	1496	E	E	B-NP	NN	B-protein	22	NMOD	B-protein
T4	I-Protein	1496	1497	-	-	B-NP	HYPH	I-protein	22	NMOD	I-protein
T4	I-Protein	1497	1505	selectin	selectin	I-NP	NN	I-protein	22	NMOD	I-protein
O	O	1506	1516	expression	expression	I-NP	NN	O	18	PMOD	O
O	O	1517	1519	in	in	B-PP	IN	O	22	NMOD	O
O	O	1520	1522	EC	EC	B-NP	NN	B-cell_type	23	PMOD	B-cell_type
O	O	1522	1523	.	.	O	.	O	10	P	O

O	O	1524	1539	Electrophoretic	Electrophoretic	B-NP	JJ	O	4	NMOD	O
O	O	1540	1548	mobility	mobility	I-NP	NN	O	4	NMOD	O
O	O	1549	1554	shift	shift	I-NP	NN	O	4	NMOD	O
O	O	1555	1561	assays	assay	I-NP	NNS	O	5	SUB	O
O	O	1562	1568	failed	fail	B-VP	VBD	O	0	ROOT	O
O	O	1569	1571	to	to	I-VP	TO	O	7	VMOD	O
O	O	1572	1576	show	show	I-VP	VB	O	5	VMOD	O
O	O	1577	1579	an	an	B-NP	DT	O	14	NMOD	O
O	O	1580	1585	alpha	alpha	I-NP	SYM	O	10	AMOD	O
O	O	1585	1586	-	-	I-NP	HYPH	O	14	NMOD	O
O	O	1586	1589	tcp	tcp	I-NP	NN	O	14	NMOD	O
O	O	1589	1590	-	-	B-NP	HYPH	O	14	NMOD	O
O	O	1590	1597	induced	induce	I-NP	VBN	O	14	NMOD	O
O	O	1598	1606	decrease	decrease	I-NP	NN	O	7	OBJ	O
O	O	1607	1609	in	in	B-PP	IN	O	14	NMOD	O
O	O	1610	1620	activation	activation	B-NP	NN	O	15	PMOD	O
O	O	1621	1623	of	of	B-PP	IN	O	16	NMOD	O
O	O	1624	1628	this	this	B-NP	DT	O	20	NMOD	O
O	O	1629	1642	transcription	transcription	I-NP	NN	B-protein	20	NMOD	B-protein
O	O	1643	1649	factor	factor	I-NP	NN	I-protein	17	PMOD	I-protein
O	O	1650	1655	after	after	B-PP	IN	O	16	NMOD	O
O	O	1656	1664	cytokine	cytokine	B-NP	NN	B-protein	23	NMOD	B-protein
O	O	1665	1676	stimulation	stimulation	I-NP	NN	O	21	PMOD	O
O	O	1676	1677	.	.	O	.	O	5	P	O

O	O	1678	1680	It	It	B-NP	PRP	O	2	SUB	O
O	O	1681	1684	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	1685	1689	been	be	I-VP	VBN	O	2	VC	O
O	O	1690	1702	hypothesized	hypothesize	I-VP	VBN	O	3	VC	O
O	O	1703	1707	that	that	B-SBAR	IN	O	4	VMOD	O
O	O	1708	1713	alpha	alpha	O	SYM	O	8	NMOD	O
O	O	1713	1714	-	-	O	HYPH	O	8	NMOD	O
O	O	1714	1717	tcp	tcp	B-NP	NN	O	9	SUB	O
O	O	1718	1722	acts	act	B-VP	VBZ	O	5	SBAR	O
O	O	1723	1725	as	as	B-PP	IN	O	9	VMOD	O
O	O	1726	1728	an	an	B-NP	DT	O	15	NMOD	O
O	O	1729	1733	anti	anti	I-NP	AFX	O	15	NMOD	O
O	O	1733	1734	-	-	I-NP	HYPH	O	15	NMOD	O
O	O	1734	1749	atherosclerotic	atherosclerotic	I-NP	JJ	O	15	NMOD	O
O	O	1750	1758	molecule	molecule	I-NP	NN	O	10	PMOD	O
O	O	1759	1761	by	by	B-PP	IN	O	9	VMOD	O
O	O	1762	1772	inhibiting	inhibit	B-VP	VBG	O	16	PMOD	O
O	O	1773	1783	generation	generation	B-NP	NN	O	17	OBJ	O
O	O	1784	1786	of	of	B-PP	IN	O	18	NMOD	O
O	O	1787	1795	oxidized	oxidize	B-NP	VBN	O	21	NMOD	O
O	O	1796	1799	LDL	LDL	I-NP	NN	B-protein	27	NMOD	B-protein
O	O	1799	1800	-	-	B-NP	HYPH	O	21	P	O
O	O	1800	1801	-	-	O	:	O	27	P	O
O	O	1801	1802	a	a	B-NP	DT	O	27	NMOD	O
O	O	1803	1811	putative	putative	I-NP	JJ	B-protein	27	NMOD	B-protein
O	O	1812	1822	triggering	trigger	I-NP	VBG	I-protein	27	NMOD	I-protein
O	O	1823	1831	molecule	molecule	I-NP	NN	I-protein	19	PMOD	I-protein
O	O	1832	1834	in	in	B-PP	IN	O	18	NMOD	O
O	O	1835	1838	the	the	B-NP	DT	O	31	NMOD	O
O	O	1839	1854	atherosclerotic	atherosclerotic	I-NP	JJ	O	31	NMOD	O
O	O	1855	1862	process	process	I-NP	NN	O	28	PMOD	O
O	O	1862	1863	.	.	O	.	O	2	P	O

O	O	1864	1867	Our	Our	B-NP	PRP$	O	2	NMOD	O
O	O	1868	1875	results	result	I-NP	NNS	O	3	SUB	O
O	O	1876	1881	point	point	B-VP	VBP	O	0	ROOT	O
O	O	1882	1884	to	to	B-PP	TO	O	3	VMOD	O
O	O	1885	1886	a	a	B-NP	DT	O	8	NMOD	O
O	O	1887	1892	novel	novel	I-NP	JJ	O	8	NMOD	O
O	O	1893	1904	alternative	alternative	I-NP	JJ	O	8	NMOD	O
O	O	1905	1914	mechanism	mechanism	I-NP	NN	O	4	PMOD	O
O	O	1915	1917	of	of	B-PP	IN	O	8	NMOD	O
O	O	1918	1924	action	action	B-NP	NN	O	9	PMOD	O
O	O	1925	1927	of	of	B-PP	IN	O	10	NMOD	O
O	O	1928	1933	alpha	alpha	B-NP	SYM	O	14	NMOD	O
O	O	1933	1934	-	-	B-VP	HYPH	O	14	NMOD	O
O	O	1934	1937	tcp	tcp	B-NP	NN	O	11	PMOD	O
O	O	1937	1938	.	.	O	.	O	3	P	O
